Legionella Testing Market Analysis Report by Application

The global legionella testing market size was valued at USD 160.0 million in 2015 and is expected to grow at a CAGR of 8.4% during forecast period.

The global Legionella Testing Market is expected to reach USD 352.6 million by 2025, according to a new study by Grand View Research Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth.

According to CDC, the number of people suffering from Legionnaires’ disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due the contaminated environment. The rising incidence of Legionellosis will drive the market growth in the coming years, especially in the industrial sector.

The conventional bacterial testing is least preferred nowadays, since it is labor intensive and time consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/legionella-testing-market

Further Key Findings From the Study Suggest:

• Water testing has been identified as the largest testing type segment in terms of revenue, due to increased water testing activities in various industries as a preventive measure to control infections
• Water testing has also been projected as fastest growing segment over the forecast period followed by IVD testing
• Among the types of water testing applications, microbial culture held the majority of market share in 2015 in terms revenue
• On the other hand, PCR is expected to be the fastest growing water testing type over the forecast period
• Urine antigen tests were identified as the largest IVD testing segment, while PCR is projected to be the fastest growing segment

Key market players in Legionella testing market include Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alere, Inc.; Roche Diagnostics; Thermo Fischer Scientific, Inc.; and Becton, Dickinson and Company (BD)